Medicare will soon determine reimbursement for inpatient CAR-T treatment

Lobbyist representing cancer hospitals are urging Medicare officials to create a new payment rule for inpatient reimbursement for new, expensive CAR-T treatments. Currently Medicare has approved outpatient rates for CAR-T; however, cancer doctors have only been comfortable providing CAR-T on an inpatient basis. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.